OptimizeRx (OPRX)
(Delayed Data from NSDQ)
$8.83 USD
-0.29 (-3.18%)
Updated Aug 6, 2024 04:00 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
OptimizeRx Corp. (OPRX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$15.19 | $20.00 | $8.00 | 72.03% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for OptimizeRx Corp. comes to $15.19. The forecasts range from a low of $8.00 to a high of $20.00. The average price target represents an increase of 72.03% from the last closing price of $8.83.
Analyst Price Targets (8 )
Broker Rating
OptimizeRx Corp. currently has an average brokerage recommendation (ABR) of 1.38 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.43 a month ago based on seven recommendations.
Of the eight recommendations deriving the current ABR, six are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 75% and 12.5% of all recommendations. A month ago, Strong Buy made up 71.43%, while Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 5 | 5 | 5 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.38 | 1.38 | 1.43 | 1.43 | 1.43 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/25/2024 | B. Riley Securities | Kyle Bauser | Strong Buy | Strong Buy |
4/9/2024 | Roth Capital Partners | Richard K Baldry | Strong Buy | Strong Buy |
4/4/2024 | JMP Securities | Constantine Kyriakos Davides | Not Available | Strong Buy |
4/1/2024 | Lake Street Capital Markets | Eric Martinuzzi | Strong Buy | Strong Buy |
4/1/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
3/31/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
3/28/2024 | William Blair | Ryan S Daniels | Strong Buy | Strong Buy |
1/3/2024 | Not Identified | Not Identified | Not Available | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.38 |
ABR (Last week) | 1.38 |
# of Recs in ABR | 8 |
Average Target Price | $15.19 |
LT Growth Rate | NA |
Industry | Computer - Software |
Industry Rank by ABR | 102 of 253 |
Current Quarter EPS Est: | -0.07 |